TOMAS MIKE 4
4 · U.S. Stem Cell, Inc. · Filed Dec 7, 2018
Insider Transaction Report
Form 4
TOMAS MIKE
DirectorCEO & President
Transactions
- Award
Stock Option (right to buy)
2018-12-03+1,500,000→ 60,041,284 totalExercise: $0.03From: 2018-12-03Exp: 2028-12-03→ Common Stock (1,500,000 underlying)
Holdings
- 9,793
Common Stock